{"id":7643,"date":"2022-06-14T14:23:32","date_gmt":"2022-06-14T14:23:32","guid":{"rendered":"https:\/\/r-biopharm.com\/?p=7643"},"modified":"2023-03-07T09:52:44","modified_gmt":"2023-03-07T09:52:44","slug":"r-biopharm-investiert-in-high-tech-start-ups","status":"publish","type":"post","link":"https:\/\/r-biopharm.com\/de\/r-biopharm-investiert-in-high-tech-start-ups\/","title":{"rendered":"R-Biopharm investiert in High-Tech-Start-ups"},"content":{"rendered":"
[vc_row][vc_column][vc_single_image image=“7626″ img_size=“full“ alignment=“center“][mk_padding_divider size=“20″][vc_column_text css=“.vc_custom_1655287210704{margin-bottom: 0px !important;}“]Der High-Tech-Gr\u00fcnderfonds f\u00f6rdert seit mehr als 17 Jahren Technologie-Start-ups in der Gr\u00fcnderphase. Jetzt hat die Initiative mit 40 Unternehmen den vierten Fonds auf den Weg gebracht \u2013 und R-Biopharm geh\u00f6rt dazu. Bereits beim First Closing erreichte der Fonds ein zugesagtes Volumen von mehr als 400 Mio. Euro. Das zweite soll noch 2022 folgen.<\/p>\n

Der High-Tech Gr\u00fcnderfonds investiert pro Jahr in 40 vielversprechende junge Unternehmen, die ihre Ideen f\u00fcr die Bereiche Digital Tech, Industrial Tech, Life Science und Chemie weiterentwickeln m\u00f6chten. R-Biopharm freut sich, mit seiner Beteilung einen weiteren wichtigen Beitrag zum Wirtschaftsstandort Deutschland leisten zu k\u00f6nnen. Denn Zukunftswille ist nicht umsonst einer der Unternehmenswerte.[\/vc_column_text][mk_padding_divider size=“20″][mk_image_slideshow images=“7662,7668,7602,7596,7590″ image_height=“450″ effect=“slide“][vc_column_text css=“.vc_custom_1655215670785{margin-bottom: 0px !important;}“]Impressionen vom First Closing Event | \u00a9HTGF \u2013 Photos by Steffen Hauser[\/vc_column_text][mk_padding_divider size=“20″][vc_column_text css=“.vc_custom_1655708325320{margin-bottom: 0px !important;}“]Als Vertreter von R-Biopharm nahmen Ute Salzbrenner, Chief Financial Officer, und Dr. Peter Schubert, Vorstand Forschung & Entwicklung, am First Closing Event f\u00fcr den HTGV Fonds IV teil. \u201eIch war \u00fcberrascht, wie Vertreter aus der Politik, dem Bankwesen und der Industrie \u2013 im Form von kleinen Gr\u00fcnderfirmen \u00fcber Hidden Champions bis zu gro\u00dfen Konzernen \u2013 in der lockeren Atmosph\u00e4re nahezu freundschaftlich ins Gespr\u00e4ch kamen und vor dem Hintergrund unserer globalen Herausforderungen gemeinsam das Richtige tun wollen\u201c, sagte Schubert anschlie\u00dfend. \u201eIch bin \u00fcberzeugt, mit unserer Teilnahme an dem HTGF Fonds IV einen positiven Beitrag sowohl im Sinne der Shareholder als auch zum gesellschaftlichen Nutzen leisten zu k\u00f6nnen.\u201c Ute Salzbrenner erg\u00e4nzte: \u201eWir hoffen, \u00fcber unser Investment in den HTGF IV interessanten Start-ups eine Chance bieten zu k\u00f6nnen und auch mit Gr\u00fcndern in Kontakt zu kommen, die f\u00fcr unsere Wachstumsstrategie interessant sind und mit denen wir \u00fcber unser HTGF IV-Engagement hinaus kooperieren k\u00f6nnen.\u201c<\/p>\n

Denn das Engagement im Gr\u00fcnderfonds ist eine weitere Facette der Technologie-F\u00f6rderung und des Technologie-Scoutings von R-Biopharm. Und nicht zuletzt ist es ein weiterer Pflasterstein auf dem Weg des Biotechnologieunternehmens zu Produkten und L\u00f6sungen, die der aktuellen Entwicklung immer einen Schritt voraus sind.[\/vc_column_text][\/vc_column][\/vc_row]\n<\/div>","protected":false},"excerpt":{"rendered":"

[vc_row][vc_column][vc_single_image image=“7626″ img_size=“full“ alignment=“center“][mk_padding_divider size=“20″][vc_column_text css=“.vc_custom_1655287210704{margin-bottom: 0px !important;}“]Der High-Tech-Gr\u00fcnderfonds f\u00f6rdert seit mehr als 17 Jahren Technologie-Start-ups in der Gr\u00fcnderphase. Jetzt hat die Initiative mit 40 Unternehmen den vierten Fonds auf den Weg gebracht \u2013 und R-Biopharm geh\u00f6rt dazu. Bereits beim First Closing erreichte der Fonds ein zugesagtes Volumen von mehr als 400 Mio. Euro. Das […]<\/p>\n","protected":false},"author":1114,"featured_media":7611,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[351],"tags":[],"class_list":["post-7643","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-newsarchiv"],"acf":[],"yoast_head":"\nR-Biopharm investiert in High-Tech-Start-ups - R-Biopharm AG<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/r-biopharm.com\/de\/r-biopharm-investiert-in-high-tech-start-ups\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"R-Biopharm investiert in High-Tech-Start-ups - R-Biopharm AG\" \/>\n<meta property=\"og:description\" content=\"[vc_row][vc_column][vc_single_image image=“7626″ img_size=“full“ alignment=“center“][mk_padding_divider size=“20″][vc_column_text css=“.vc_custom_1655287210704{margin-bottom: 0px !important;}“]Der High-Tech-Gr\u00fcnderfonds f\u00f6rdert seit mehr als 17 Jahren Technologie-Start-ups in der Gr\u00fcnderphase. Jetzt hat die Initiative mit 40 Unternehmen den vierten Fonds auf den Weg gebracht \u2013 und R-Biopharm geh\u00f6rt dazu. Bereits beim First Closing erreichte der Fonds ein zugesagtes Volumen von mehr als 400 Mio. Euro. Das […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/r-biopharm.com\/de\/r-biopharm-investiert-in-high-tech-start-ups\/\" \/>\n<meta property=\"og:site_name\" content=\"R-Biopharm AG\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-14T14:23:32+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-03-07T09:52:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/r-biopharm.com\/wp-content\/uploads\/htgf_2.png\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"niclas\" \/>\n<meta name=\"twitter:label1\" content=\"Verfasst von\" \/>\n\t<meta name=\"twitter:data1\" content=\"niclas\" \/>\n\t<meta name=\"twitter:label2\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data2\" content=\"2\u00a0Minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/r-biopharm.com\\\/de\\\/r-biopharm-investiert-in-high-tech-start-ups\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/r-biopharm.com\\\/de\\\/r-biopharm-investiert-in-high-tech-start-ups\\\/\"},\"author\":{\"name\":\"niclas\",\"@id\":\"https:\\\/\\\/r-biopharm.com\\\/#\\\/schema\\\/person\\\/1f2853ffae1847d6375c365a249e8cb4\"},\"headline\":\"R-Biopharm investiert in High-Tech-Start-ups\",\"datePublished\":\"2022-06-14T14:23:32+00:00\",\"dateModified\":\"2023-03-07T09:52:44+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/r-biopharm.com\\\/de\\\/r-biopharm-investiert-in-high-tech-start-ups\\\/\"},\"wordCount\":398,\"image\":{\"@id\":\"https:\\\/\\\/r-biopharm.com\\\/de\\\/r-biopharm-investiert-in-high-tech-start-ups\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/r-biopharm.com\\\/wp-content\\\/uploads\\\/htgf_2.png\",\"articleSection\":[\"Newsarchiv\"],\"inLanguage\":\"de\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/r-biopharm.com\\\/de\\\/r-biopharm-investiert-in-high-tech-start-ups\\\/\",\"url\":\"https:\\\/\\\/r-biopharm.com\\\/de\\\/r-biopharm-investiert-in-high-tech-start-ups\\\/\",\"name\":\"R-Biopharm investiert in High-Tech-Start-ups - R-Biopharm AG\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/r-biopharm.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/r-biopharm.com\\\/de\\\/r-biopharm-investiert-in-high-tech-start-ups\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/r-biopharm.com\\\/de\\\/r-biopharm-investiert-in-high-tech-start-ups\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/r-biopharm.com\\\/wp-content\\\/uploads\\\/htgf_2.png\",\"datePublished\":\"2022-06-14T14:23:32+00:00\",\"dateModified\":\"2023-03-07T09:52:44+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/r-biopharm.com\\\/#\\\/schema\\\/person\\\/1f2853ffae1847d6375c365a249e8cb4\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/r-biopharm.com\\\/de\\\/r-biopharm-investiert-in-high-tech-start-ups\\\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/r-biopharm.com\\\/de\\\/r-biopharm-investiert-in-high-tech-start-ups\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/r-biopharm.com\\\/de\\\/r-biopharm-investiert-in-high-tech-start-ups\\\/#primaryimage\",\"url\":\"https:\\\/\\\/r-biopharm.com\\\/wp-content\\\/uploads\\\/htgf_2.png\",\"contentUrl\":\"https:\\\/\\\/r-biopharm.com\\\/wp-content\\\/uploads\\\/htgf_2.png\",\"width\":800,\"height\":800},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/r-biopharm.com\\\/de\\\/r-biopharm-investiert-in-high-tech-start-ups\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/r-biopharm.com\\\/de\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"R-Biopharm investiert in High-Tech-Start-ups\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/r-biopharm.com\\\/#website\",\"url\":\"https:\\\/\\\/r-biopharm.com\\\/\",\"name\":\"R-Biopharm AG\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/r-biopharm.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/r-biopharm.com\\\/#\\\/schema\\\/person\\\/1f2853ffae1847d6375c365a249e8cb4\",\"name\":\"niclas\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1dfb0993bf8db0eca7425703a4efa851020c2ae35c8fa06cb76e6981abceeb33?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1dfb0993bf8db0eca7425703a4efa851020c2ae35c8fa06cb76e6981abceeb33?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1dfb0993bf8db0eca7425703a4efa851020c2ae35c8fa06cb76e6981abceeb33?s=96&d=mm&r=g\",\"caption\":\"niclas\"},\"url\":\"https:\\\/\\\/r-biopharm.com\\\/de\\\/author\\\/niclas\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"R-Biopharm investiert in High-Tech-Start-ups - R-Biopharm AG","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/r-biopharm.com\/de\/r-biopharm-investiert-in-high-tech-start-ups\/","og_locale":"de_DE","og_type":"article","og_title":"R-Biopharm investiert in High-Tech-Start-ups - R-Biopharm AG","og_description":"[vc_row][vc_column][vc_single_image image=“7626″ img_size=“full“ alignment=“center“][mk_padding_divider size=“20″][vc_column_text css=“.vc_custom_1655287210704{margin-bottom: 0px !important;}“]Der High-Tech-Gr\u00fcnderfonds f\u00f6rdert seit mehr als 17 Jahren Technologie-Start-ups in der Gr\u00fcnderphase. Jetzt hat die Initiative mit 40 Unternehmen den vierten Fonds auf den Weg gebracht \u2013 und R-Biopharm geh\u00f6rt dazu. Bereits beim First Closing erreichte der Fonds ein zugesagtes Volumen von mehr als 400 Mio. Euro. Das […]","og_url":"https:\/\/r-biopharm.com\/de\/r-biopharm-investiert-in-high-tech-start-ups\/","og_site_name":"R-Biopharm AG","article_published_time":"2022-06-14T14:23:32+00:00","article_modified_time":"2023-03-07T09:52:44+00:00","og_image":[{"width":800,"height":800,"url":"https:\/\/r-biopharm.com\/wp-content\/uploads\/htgf_2.png","type":"image\/png"}],"author":"niclas","twitter_misc":{"Verfasst von":"niclas","Gesch\u00e4tzte Lesezeit":"2\u00a0Minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/r-biopharm.com\/de\/r-biopharm-investiert-in-high-tech-start-ups\/#article","isPartOf":{"@id":"https:\/\/r-biopharm.com\/de\/r-biopharm-investiert-in-high-tech-start-ups\/"},"author":{"name":"niclas","@id":"https:\/\/r-biopharm.com\/#\/schema\/person\/1f2853ffae1847d6375c365a249e8cb4"},"headline":"R-Biopharm investiert in High-Tech-Start-ups","datePublished":"2022-06-14T14:23:32+00:00","dateModified":"2023-03-07T09:52:44+00:00","mainEntityOfPage":{"@id":"https:\/\/r-biopharm.com\/de\/r-biopharm-investiert-in-high-tech-start-ups\/"},"wordCount":398,"image":{"@id":"https:\/\/r-biopharm.com\/de\/r-biopharm-investiert-in-high-tech-start-ups\/#primaryimage"},"thumbnailUrl":"https:\/\/r-biopharm.com\/wp-content\/uploads\/htgf_2.png","articleSection":["Newsarchiv"],"inLanguage":"de"},{"@type":"WebPage","@id":"https:\/\/r-biopharm.com\/de\/r-biopharm-investiert-in-high-tech-start-ups\/","url":"https:\/\/r-biopharm.com\/de\/r-biopharm-investiert-in-high-tech-start-ups\/","name":"R-Biopharm investiert in High-Tech-Start-ups - R-Biopharm AG","isPartOf":{"@id":"https:\/\/r-biopharm.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/r-biopharm.com\/de\/r-biopharm-investiert-in-high-tech-start-ups\/#primaryimage"},"image":{"@id":"https:\/\/r-biopharm.com\/de\/r-biopharm-investiert-in-high-tech-start-ups\/#primaryimage"},"thumbnailUrl":"https:\/\/r-biopharm.com\/wp-content\/uploads\/htgf_2.png","datePublished":"2022-06-14T14:23:32+00:00","dateModified":"2023-03-07T09:52:44+00:00","author":{"@id":"https:\/\/r-biopharm.com\/#\/schema\/person\/1f2853ffae1847d6375c365a249e8cb4"},"breadcrumb":{"@id":"https:\/\/r-biopharm.com\/de\/r-biopharm-investiert-in-high-tech-start-ups\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/r-biopharm.com\/de\/r-biopharm-investiert-in-high-tech-start-ups\/"]}]},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/r-biopharm.com\/de\/r-biopharm-investiert-in-high-tech-start-ups\/#primaryimage","url":"https:\/\/r-biopharm.com\/wp-content\/uploads\/htgf_2.png","contentUrl":"https:\/\/r-biopharm.com\/wp-content\/uploads\/htgf_2.png","width":800,"height":800},{"@type":"BreadcrumbList","@id":"https:\/\/r-biopharm.com\/de\/r-biopharm-investiert-in-high-tech-start-ups\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/r-biopharm.com\/de\/"},{"@type":"ListItem","position":2,"name":"R-Biopharm investiert in High-Tech-Start-ups"}]},{"@type":"WebSite","@id":"https:\/\/r-biopharm.com\/#website","url":"https:\/\/r-biopharm.com\/","name":"R-Biopharm AG","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/r-biopharm.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Person","@id":"https:\/\/r-biopharm.com\/#\/schema\/person\/1f2853ffae1847d6375c365a249e8cb4","name":"niclas","image":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/secure.gravatar.com\/avatar\/1dfb0993bf8db0eca7425703a4efa851020c2ae35c8fa06cb76e6981abceeb33?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/1dfb0993bf8db0eca7425703a4efa851020c2ae35c8fa06cb76e6981abceeb33?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1dfb0993bf8db0eca7425703a4efa851020c2ae35c8fa06cb76e6981abceeb33?s=96&d=mm&r=g","caption":"niclas"},"url":"https:\/\/r-biopharm.com\/de\/author\/niclas\/"}]}},"_links":{"self":[{"href":"https:\/\/r-biopharm.com\/de\/wp-json\/wp\/v2\/posts\/7643","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/r-biopharm.com\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/r-biopharm.com\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/r-biopharm.com\/de\/wp-json\/wp\/v2\/users\/1114"}],"replies":[{"embeddable":true,"href":"https:\/\/r-biopharm.com\/de\/wp-json\/wp\/v2\/comments?post=7643"}],"version-history":[{"count":5,"href":"https:\/\/r-biopharm.com\/de\/wp-json\/wp\/v2\/posts\/7643\/revisions"}],"predecessor-version":[{"id":7699,"href":"https:\/\/r-biopharm.com\/de\/wp-json\/wp\/v2\/posts\/7643\/revisions\/7699"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/r-biopharm.com\/de\/wp-json\/wp\/v2\/media\/7611"}],"wp:attachment":[{"href":"https:\/\/r-biopharm.com\/de\/wp-json\/wp\/v2\/media?parent=7643"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/r-biopharm.com\/de\/wp-json\/wp\/v2\/categories?post=7643"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/r-biopharm.com\/de\/wp-json\/wp\/v2\/tags?post=7643"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}